Outpatient 131I Treatment for a Patient with Graves' Disease Receiving Hemodialysis

被引：1

作者：

Suzuki, Miho ^{[1
]}

Noh, Jaeduk Yoshimura ^{[1
]}

Sugino, Kiminori ^{[1
]}

Ito, Koichi ^{[1
]}

机构：

[1] Ito Hosp, Tokyo, Japan

来源：

INTERNAL MEDICINE | 2016年 / 55卷 / 22期

关键词：

I-131; therapy; hyperthyroidism; hemodialysis; end-stage renal disease; a hospital-linkage system; radioactivity measurement; CHRONIC-RENAL-FAILURE; ANTITHYROID DRUGS; HYPERTHYROIDISM; THERAPY; RADIOIODINE; PREDICTION; DIAGNOSIS; REMISSION; DIALYSIS;

D O I：

10.2169/internalmedicine.55.6980

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A patient presented with hyperthyroidism and end-stage renal disease requiring hemodialysis that was difficult to control despite increased dosages of anti-thyroid drugs. The condition could finally be controlled by I-131 radioactive iodine therapy (RIT) and hemodialysis provided under a hospital-linkage system. During three hemodialysis sessions after the oral administration of I-131, we measured the radioactivity released from the patient and the radioactivity of the devices/tools used. The radioactivity of the devices/tools was managed by allowing the isotope to decay into non-radioactive elements. Our experience suggests that outpatient RIT may provide a safe and convenient means of treating Graves' disease, even in patients receiving hemodialysis.

引用

页码：3309 / 3313

页数：5

共 19 条

[1]

Akiba Takashi, 2013, Nihon Naika Gakkai Zasshi, V102, P2473

[2] Diagnosis and radioablation treatment of toxic multinodular goiter in a hemodialysis patient [J].